Vanguard Group’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,260,942
Closed -$10M 4431
2025
Q2
$10M Buy
1,260,942
+212,119
+20% +$951K ﹤0.01% 2898
2025
Q1
$1.87M Buy
1,048,823
+73,350
+8% +$165K ﹤0.01% 3512
2024
Q4
$1.66M Buy
975,473
+70,742
+8% +$209K ﹤0.01% 3625
2024
Q3
$3.08M Buy
904,731
+90,000
+11% +$333K ﹤0.01% 3431
2024
Q2
$3.26M Sell
814,731
-79,742
-9% -$273K ﹤0.01% 3407
2024
Q1
$3.05M Buy
894,473
+95,276
+12% +$297K ﹤0.01% 3458
2023
Q4
$2.7M Buy
799,197
+5,231
+0.7% +$26.9K ﹤0.01% 3491
2023
Q3
$4.28M Buy
793,966
+1,730
+0.2% +$11.9K ﹤0.01% 3314
2023
Q2
$7.45M Buy
792,236
+63,623
+9% +$602K ﹤0.01% 3114
2023
Q1
$7.13M Sell
728,613
-8,400
-1% -$94.4K ﹤0.01% 3136
2022
Q4
$9.21M Buy
737,013
+371,587
+102% +$4.56M ﹤0.01% 2982
2022
Q3
$3.33M Buy
365,426
+11,218
+3% +$82.3K ﹤0.01% 3528
2022
Q2
$914K Sell
354,208
-30,990
-8% -$122K ﹤0.01% 4117
2022
Q1
$2.71M Buy
+385,198
New +$5.08M ﹤0.01% 3824

Other funds holding VIGL